General InformationCalico Labs is an Alphabet-backed biotech company based in San Francisco, California, founded in 2013 with 201-500 employees focused on longevity and aging research.
Funding & FinancialsCalico is backed by Alphabet Inc. with estimated total funding exceeding $1.5 billion, operating as a subsidiary with continuous internal funding rather than traditional venture rounds.
Leadership & TeamArthur D. Levinson, the former Genentech CEO, serves as Chairman and CEO, bringing deep biotech expertise and established industry relationships to lead the organization.
Recent ActivityCalico has recently expanded its drug pipeline with multiple candidates in preclinical and early clinical development stages, while continuing strategic collaborations with academic institutions on aging research.